AP - Federal advisers are considering whether a proposed weight-loss drug raises the risk of depression, a finding that could lead to stern warnings on the medication if it is approved.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.